3M (MMM) Stock Drops 5% on Court Verdict Related to Military Earplugs, JPMorgan Sees Up To $1.5 Trillion in Potential Liabilities
- Wall Street ends lower as Cisco and Apple sink
- A Recession Could Push S&P 500 to 3360 - Goldman Sachs
- Palo Alto Networks Shares Surge 11% on Q3 Earnings Beat and Raise
- Twitter (TWTR) Says Musk Deal Not 'On-Hold', Won't Renegotiate Price
- After-Hours Stock Movers 05/19: Palo Alto Ramps on Strong Results; Ross Stores Plunges (more...)
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Shares of 3M (NYSE: MMM) are down over 5% today after a federal jury in Florida awarded $55 million each to two U.S. Army veterans who sustained hearing damage after using combat earplugs developed by the company.
This marks the largest verdict in a series of trials over the earplugs' safety. Jurors in Pensacola, Florida, awarded a total of $110 million to Ronald Sloan and William Wayman who claimed that 3M's Combat Arms Earplugs Version 2 they used were defective.
But Sloan and Wayman are just the two of almost 300,000 U.S. army members who took legal action against 3M on claims that they sustained hearing damage after using their earplug products. This marks the largest-ever federal mass tort litigation in the U.S.
The two veterans each received $15 million in compensatory damages and $40 million in punitive damages, said the plaintiff’s lawyers.
"Juries continue to find that 3M's earplugs were defective and that they are responsible for causing irreparable hearing damage to those who served our country," said lawyers Bryan Aylstock, Shelley Hutson and Christopher Seeger in a joint statement.
JPMorgan analyst C. Stephen Tusa sees “significant” potential liabilities facing 3M.
“While PFAS appears to get most of the investor attention, combat arms litigation has recently emerged as a more readily analyzable, potentially material liability, at least by the simple math. What’s unique here is that there is a quantifiable case set and a number of bellwether trials that help us create a framework to understand the potential exposure, which is significant. In the most onerous simple math, liabilities could be $1.5 T for the total caseload of ~285,000,” Tusa wrote in a client note.
By Senad Karaahmetovic | [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Positive on Rocket Pharmaceuticals (RCKT), 'we see current share levels as an attractive entry point to capture longer-term pipeline potential'
- UPDATE: DA Davidson Downgrades Thor Industries Inc. (THO) to Underperform
- Banco Bilbao Vizcaya Argentaria SA (BBVA:SM) (BBVA) PT Lowered to EUR6 at JPMorgan
Create E-mail Alert Related CategoriesAnalyst Comments, Hot Comments, Litigation
Related EntitiesJPMorgan, Stephen Tusa, Senad Karaahmetovic
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!